The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study of combretastatin A4-phosphate (CA4P) in the treatment of well-differentiated, low- to intermediate-grade, unresectable, recurrent, or metastatic pancreatic, or GI neuroendocrine tumors/carcinoid (GI-NETs/PNETs) with elevated biomarkers.
 
Steven K. Libutti
Stock and Other Ownership Interests - AAVP Biosystems
Research Funding - Oxigene (Inst)
Patents, Royalties, Other Intellectual Property - National Cancer Institute
Travel, Accommodations, Expenses - Oxigene
 
Lowell Brian Anthony
No Relationships to Disclose
 
David J. Chaplin
Employment - Mateon Therapeutics
Leadership - Mateon Therapeutics
Stock and Other Ownership Interests - Mateon Therapeutics
 
Julie Ann Sosa
Other Relationship - AstraZeneca; GlaxoSmithKline; Lilly; Novo Nordisk